Boothbay Fund Management, LLC Alpine Immune Sciences, Inc. Transaction History

Boothbay Fund Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$17.75 - $41.6 $867,105 - $2.03 Million	-48,851 Reduced 41.82%	67,972 $2.69 Million
Q4 2023 Feb 14, 2024	BUY	$8.54 - $20.22 $997,668 - $2.36 Million	116,823 New	116,823 $2.23 Million
Q3 2021 Nov 15, 2021	SELL	$8.19 - $11.31 $290,933 - $401,765	-35,523 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$8.81 - $15.03 $11,171 - $19,058	-1,268 Reduced 3.45%	35,523 $320,000
Q1 2021 May 17, 2021	BUY	$10.02 - $13.92 $264,137 - $366,945	26,361 Added 252.74%	36,791 $390,000
Q4 2020 Feb 12, 2021	BUY	$7.42 - $15.96 $77,390 - $166,462	10,430 New	10,430 $131,000

56.2K

Ticker ALPN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,006,700
Description
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.